8 completed. 8 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 8 |
Follow ravidasvir: new trials by email Literature Review of ravidasvir trials Research Report on ravidasvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Relative Bioavailability of ASC18 Tablets vs Reference Tablets in Healthy Volunteers ASC18, ravidasvir and sofosbuvir - Healthy | Phase 1 | Completed | Ascletis Pharmaceuticals Co., Ltd. | 50 | 2020-03-20 | 2021-01-11 |
| A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China Ravidasvir 50mg, Ravidasvir 200mg - Chronic Hepatitis c | Phase 1 | Completed | Ascletis Pharmaceuticals Co., Ltd. | 12 | 2018-01-15 | 2018-06-29 |
| Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China Danoprevir, Ritonavir, Ravidasvir - HCV | Phase 1 | Completed | Ascletis Pharmaceuticals Co., Ltd. | 18 | 2017-08-08 | 2018-01-17 |
| Pharmacokinetics and Safety of Ravidasvir and Danoprevir/r in Healthy Volunteers China Ravidasvir, Danoprevir, Ritonavir - Healthy | Phase 1 | Completed | Ascletis Pharmaceuticals Co., Ltd. | 18 | 2016-07-15 | 2018-06-29 |
| Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations PPI-668 tablet, PPI-668 capsule - Pharmacokinetic Assessments in Healthy Volunteers | Phase 1 | Completed | Presidio Pharmaceuticals, Inc. | 12 | 2014-10-01 | 2015-01-22 |
| Phase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations PPI-668 capsule, PPI-668 tablet - Pharmacokinetic Assessments in Healthy Volunteers | Phase 1 | Completed | Presidio Pharmaceuticals, Inc. | 24 | 2013-10-01 | 2014-01-09 |
| A Drug Interaction Study of the Effects of PPI-668 on the Pharmacokinetics of Midazolam and Omeprazole PPI-668, Midazolam, Omeprazole - Pharmacokinetic Assessments in Healthy Volunteers | Phase 1 | Completed | Presidio Pharmaceuticals, Inc. | 24 | 2013-02-01 | 2013-03-26 |
| A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1 PPI-668, Placebo - Hepatitis C, Chronic | Phase 1 | Completed | Presidio Pharmaceuticals, Inc. | 82 | 2011-10-01 | 2012-11-16 |
Hepatitis C, Chronic (2) · Hepatitis C (1)
Ascletis Pharmaceuticals Co., Ltd. (4) · Presidio Pharmaceuticals, Inc. (4)
United States (4) · China (3) · Australia (1) · New Zealand (1)
Nathaniel Brown, MD (2) · Huoling Tang, PhD (1) · Nathaniel Brown, M.D. (1) · Paul Rice, MD (1) · Yahong Chen, MD (1) · Yahong Chen, Master (1)